Circadian variations in laboratory measurements of coagulation assays after administration of rivaroxaban or warfarin in patients with nonvalvular atrial fibrillation-Reference-Cited by-同舟云学术

Circadian variations in laboratory measurements of coagulation assays after administration of rivaroxaban or warfarin in patients with nonvalvular atrial fibrillation

Published:2016-12 Issue:6 Volume:68 Page:529-535
ISSN:0914-5087
Container-title:Journal of Cardiology
language:en
Short-container-title:Journal of Cardiology

Author:

Hitaka Yuka,Ogawa Masahiro,Zhang Bo,Goto Shunichiro,Nagata Yoshihisa,Morii Joji,Imaizumi Satoshi,Yasuda Tomoo,Matsumoto Naomichi,Matsunaga Akira,Saku Keijiro

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference10 articles.

1. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation;Patel;N Engl J Med,2011

2. Rivaroxaban vs. warfarin in Japanese patients with non-valvular atrial fibrillation in relation to age;Hori;Circ J,2014

3. Rivaroxaban vs. warfarin in Japanese patients with atrial fibrillation – the J-ROCKET AF study;Hori;Circ J,2012

4. Safety, pharmacokinetics and pharmacodynamics of single/multiple doses of the oral, direct Factor Xa inhibitor rivaroxaban in healthy Chinese subjects;Zhao;Br J Clin Pharmacol,2009

5. Population pharmacokinetics and pharmacodynamics of rivaroxaban in patients with non-valvular atrial fibrillation: results from ROCKET AF;Girgis;J Clin Pharmacol,2014

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effect of rivaroxaban on biomarkers in blood and plasma: a review of preclinical and clinical evidence;Journal of Thrombosis and Thrombolysis;2023-02-06

2. Comparisons of Edoxaban Versus Warfarin on Levels of Plasma Prothrombin Fragment in Patients With Nonvalvular Atrial Fibrillation;The American Journal of Cardiology;2020-12

3. Effects of home prothrombin international ratio (PT-INR) management in children with mechanical prosthetic valves – Importance of individual correlations between laboratory and CoaguChek device PT-INRs;Journal of Cardiology;2018-02

4. Factor Xa inhibition by rivaroxaban in the trough steady state can significantly reduce thrombin generation;British Journal of Clinical Pharmacology;2017-10-18